Muscle physiology in spasticity and muscle stiffness

Area of Science:

• Physiology
• Neurology
• Biomedical Engineering

Background:

• Spasticity is a common neurological disorder affecting sensorimotor control, leading to increased muscle stiffness and movement resistance.
• Conditions like multiple sclerosis, cerebral palsy, spinal cord injury, stroke, and traumatic brain injury are frequently associated with spasticity.
• Muscle architectural changes are increasingly recognized as contributors to passive resistance and reflex potentiation in spasticity.

Purpose of the Study:

• To investigate the physiological mechanisms underlying spasticity and muscle stiffness.
• To explore the role of the muscle extracellular matrix (ECM), specifically hyaluronan (HA), in modulating muscle stiffness.
• To elucidate the clinical implications of these mechanisms for patient treatment and disability prevention.

Main Methods:

• Examination of physiological changes in spastic muscles.
• Focus on the mechanisms of extracellular matrix modulation, particularly hyaluronan's role.
• Review of recent developments in spasticity research and the hyaluronan hypothesis of muscle stiffness.

Main Results:

• The hyaluronan hypothesis suggests that HA accumulation and alteration in the muscle ECM increase viscosity and passive mechanical resistance.
• Increased ECM viscosity may enhance muscle sensitivity to stretch, potentiating spasticity.
• These changes can lead to fibrosis and contracture through myofibroblast differentiation.

Conclusions:

• Hyaluronan plays a pivotal role in modulating muscle extracellular matrix properties, contributing to stiffness in spasticity.
• Understanding HA's role in ECM dynamics offers potential for novel therapeutic strategies.
• Targeting HA could mitigate stiffness and prevent long-term disability in spasticity patients.